Sökning: WFRF:(Montalescot Gilles) >
P2Y12 receptor inhi...
P2Y12 receptor inhibitors in patients with non-STelevation acute coronary syndrome in the real world : Use, patient selection, and outcomes from contemporary European registries
-
- Zeymer, Uwe (författare)
- Klinikum Ludwigshafen
-
- Widimsky, Petr (författare)
- Charles University in Prague
-
- Danchin, Nicolas (författare)
- Hôpital Européen Georges-Pompidou
-
visa fler...
-
- Lettino, Maddalena (författare)
- Humanitas Research Hospital
-
- Bardaji, Alfredo (författare)
- Hospital Joan XXIII
-
- Barrabes, Jose A. (författare)
- Vall d'Hebron University Hospital
-
- Cequier, Angel (författare)
- Bellvitge University Hospital-IDIBELL
-
- Claeys, Marc J. (författare)
- Antwerp University Hospital
-
- De Luca, Leonardo (författare)
- European Hospital
-
- Dörler, Jakob (författare)
- Medical University of Innsbruck
-
- Erlinge, David (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital
-
- Erne, Paul (författare)
- University of Zurich
-
- Goldstein, Patrick (författare)
- Lille University Hospital
-
- Koul, Sasha M. (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups,Skåne University Hospital
-
- Lemesle, Gilles (författare)
- Lille University Hospital
-
- Lüscher, Thomas F. (författare)
- University of Zurich
-
- Matter, Christian M. (författare)
- University of Zurich
-
- Montalescot, Gilles (författare)
- Pitié-Salpêtrière University Hospital
-
- Radovanovic, Dragana (författare)
- University of Zurich
-
- Sendón, Jose Lopez (författare)
- University Hospital La Paz
-
- Tousek, Petr (författare)
- Charles University in Prague
-
- Weidinger, Franz (författare)
- Hospital Rudolfstiftung
-
- Weston, Clive F.M. (författare)
- Swansea University
-
- Zaman, Azfar (författare)
- Freeman Hospital
-
- Andell, Pontus (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups,Skåne University Hospital
-
- Li, Jin (författare)
- University of Zurich
-
- Wouter Jukema, J. (författare)
- Leiden University Medical Centre
-
visa färre...
-
(creator_code:org_t)
-
- 2016-03-02
- 2016
- Engelska 15 s.
-
Ingår i: European Heart Journal - Cardiovascular Pharmacotherapy. - : Oxford University Press (OUP). - 2055-6837 .- 2055-6845. ; 2:4, s. 229-243
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://academic.oup...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aims Non-ST-elevation acute coronary syndrome (NSTE-ACS) is present in about 60-70% of patients admitted with acute coronary syndromes in clinical practice. This study provides a 'real-life' overview of NSTE-ACS patient characteristics, dual antiplatelet therapy clinical practice, and outcomes at both the time of discharge from hospital and up to 1-year post-discharge. Methods and results A total of 10 registries (documenting 84 054 NSTE-ACS patients) provided data in a systematic manner on patient characteristics and outcomes for NSTE-ACS in general, and 6 of these (with 52 173 NSTE-ACS patients) also provided more specific data according to P2Y12 receptor inhibitor used. Unadjusted analyses were performed at the study level, and no formal meta-Analysis was performed due to large heterogeneity between studies in the settings, patient characteristics, and outcome definitions. All-cause death rates across registries ranged from 0.76 to 4.79% in-hospital, from 1.61 to 6.65% at 30 days, from 3.66 to 7.16% at 180 days, and from 3.14 to 9.73% at 1 year. Major bleeding events were reported in up to 2.77% of patients while in hospital (in seven registries), up to 1.08% at 30 days (data from one registry only), and 2.06% at 1 year (one registry). Conclusions There were substantial differences in the use of and patient selection for clopidogrel, prasugrel, and ticagrelor, which were associated with differences in short-And long-Term ischaemic and bleeding events. In future registries, data collection should be performed in a more standardized way with respect to endpoints, definitions, and time points.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Acute coronary syndromes
- Antiplatelets
- Clopidogrel
- Non-ST-segment elevation
- Observational
- P2Y12 receptor inhibitors
- Prasugrel
- Ticagrelor
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Zeymer, Uwe
-
Widimsky, Petr
-
Danchin, Nicolas
-
Lettino, Maddale ...
-
Bardaji, Alfredo
-
Barrabes, Jose A ...
-
visa fler...
-
Cequier, Angel
-
Claeys, Marc J.
-
De Luca, Leonard ...
-
Dörler, Jakob
-
Erlinge, David
-
Erne, Paul
-
Goldstein, Patri ...
-
Koul, Sasha M.
-
Lemesle, Gilles
-
Lüscher, Thomas ...
-
Matter, Christia ...
-
Montalescot, Gil ...
-
Radovanovic, Dra ...
-
Sendón, Jose Lop ...
-
Tousek, Petr
-
Weidinger, Franz
-
Weston, Clive F. ...
-
Zaman, Azfar
-
Andell, Pontus
-
Li, Jin
-
Wouter Jukema, J ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
European Heart J ...
- Av lärosätet
-
Lunds universitet